Alice Weaver Flaherty, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obsessive Behavior | 1 | 2022 | 48 | 0.790 |
Why?
|
| Deep Brain Stimulation | 5 | 2018 | 850 | 0.360 |
Why?
|
| Mood Disorders | 3 | 2018 | 1128 | 0.330 |
Why?
|
| Basal Ganglia | 7 | 2007 | 549 | 0.330 |
Why?
|
| Internal Capsule | 2 | 2007 | 134 | 0.300 |
Why?
|
| Parkinson Disease | 8 | 2017 | 2895 | 0.290 |
Why?
|
| Saimiri | 5 | 1995 | 337 | 0.280 |
Why?
|
| Vocabulary | 1 | 2007 | 165 | 0.280 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 518 | 0.260 |
Why?
|
| Tourette Syndrome | 2 | 2007 | 400 | 0.260 |
Why?
|
| Writing | 1 | 2007 | 199 | 0.250 |
Why?
|
| Somatosensory Cortex | 3 | 1995 | 510 | 0.240 |
Why?
|
| Motor Cortex | 5 | 2000 | 1003 | 0.240 |
Why?
|
| Glutamate Decarboxylase | 2 | 2017 | 240 | 0.210 |
Why?
|
| Dyskinesias | 1 | 2023 | 79 | 0.210 |
Why?
|
| Research Personnel | 1 | 2007 | 590 | 0.210 |
Why?
|
| Psychotherapeutic Processes | 1 | 2021 | 50 | 0.190 |
Why?
|
| Confusion | 1 | 2023 | 277 | 0.190 |
Why?
|
| Physician's Role | 1 | 2008 | 927 | 0.180 |
Why?
|
| Psychoanalysis | 1 | 2021 | 84 | 0.180 |
Why?
|
| Publishing | 1 | 2007 | 835 | 0.170 |
Why?
|
| Psychotherapy | 3 | 2023 | 1645 | 0.170 |
Why?
|
| Subthalamic Nucleus | 3 | 2018 | 203 | 0.170 |
Why?
|
| Electroconvulsive Therapy | 2 | 2018 | 506 | 0.160 |
Why?
|
| Frontal Lobe | 1 | 2005 | 1410 | 0.160 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 1660 | 0.150 |
Why?
|
| Conversion Disorder | 1 | 2021 | 201 | 0.150 |
Why?
|
| Physician-Patient Relations | 2 | 2010 | 3278 | 0.150 |
Why?
|
| Temporal Lobe | 1 | 2005 | 1714 | 0.150 |
Why?
|
| Putamen | 3 | 1994 | 289 | 0.150 |
Why?
|
| Brain Mapping | 7 | 2013 | 6601 | 0.140 |
Why?
|
| Pain, Intractable | 1 | 2018 | 132 | 0.140 |
Why?
|
| alpha-Synuclein | 2 | 2015 | 772 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2007 | 1462 | 0.130 |
Why?
|
| Behavior | 1 | 2018 | 535 | 0.120 |
Why?
|
| Neostriatum | 1 | 1995 | 231 | 0.110 |
Why?
|
| Microelectrodes | 2 | 2013 | 304 | 0.110 |
Why?
|
| Risk-Taking | 1 | 2018 | 1021 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2023 | 1484 | 0.100 |
Why?
|
| Globus Pallidus | 1 | 1994 | 248 | 0.100 |
Why?
|
| Substantia Nigra | 1 | 1994 | 346 | 0.100 |
Why?
|
| Corpus Striatum | 3 | 1994 | 1218 | 0.100 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2011 | 43 | 0.090 |
Why?
|
| Aptitude | 1 | 2011 | 43 | 0.090 |
Why?
|
| Gene Transfer Techniques | 2 | 2017 | 1216 | 0.090 |
Why?
|
| Central Nervous System Agents | 1 | 2011 | 72 | 0.090 |
Why?
|
| Tremor | 1 | 2011 | 198 | 0.080 |
Why?
|
| Wheat Germ Agglutinin-Horseradish Peroxidase Conjugate | 3 | 1995 | 36 | 0.080 |
Why?
|
| Neural Pathways | 5 | 2011 | 3085 | 0.080 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 616 | 0.080 |
Why?
|
| Wheat Germ Agglutinins | 3 | 1993 | 47 | 0.080 |
Why?
|
| Axonal Transport | 3 | 1994 | 178 | 0.080 |
Why?
|
| Movement | 2 | 2007 | 1462 | 0.080 |
Why?
|
| Horseradish Peroxidase | 3 | 1993 | 169 | 0.080 |
Why?
|
| Cholecalciferol | 1 | 2013 | 550 | 0.080 |
Why?
|
| Paraproteinemias | 1 | 2011 | 252 | 0.080 |
Why?
|
| Literature | 1 | 2008 | 15 | 0.080 |
Why?
|
| Brain | 3 | 2013 | 27171 | 0.070 |
Why?
|
| Thalamus | 2 | 2007 | 1048 | 0.070 |
Why?
|
| Cultural Competency | 1 | 2011 | 303 | 0.070 |
Why?
|
| Neurons | 4 | 2018 | 9525 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 663 | 0.070 |
Why?
|
| Electrodes, Implanted | 2 | 2005 | 830 | 0.070 |
Why?
|
| Functional Laterality | 3 | 2007 | 2243 | 0.070 |
Why?
|
| Electrophysiology | 3 | 2013 | 1263 | 0.070 |
Why?
|
| Drive | 1 | 2005 | 34 | 0.060 |
Why?
|
| Psychomotor Performance | 2 | 2007 | 1881 | 0.060 |
Why?
|
| Hand | 3 | 2004 | 909 | 0.060 |
Why?
|
| Ablation Techniques | 1 | 2008 | 254 | 0.060 |
Why?
|
| Electric Stimulation | 3 | 1995 | 1735 | 0.060 |
Why?
|
| Imagination | 1 | 2005 | 213 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1348 | 0.060 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 869 | 0.050 |
Why?
|
| Empathy | 1 | 2008 | 474 | 0.050 |
Why?
|
| Limbic System | 1 | 2005 | 418 | 0.050 |
Why?
|
| Enkephalins | 2 | 1993 | 139 | 0.050 |
Why?
|
| Models, Neurological | 2 | 2005 | 1747 | 0.050 |
Why?
|
| Humans | 28 | 2023 | 765968 | 0.050 |
Why?
|
| Gyrus Cinguli | 1 | 2008 | 1117 | 0.050 |
Why?
|
| Depressive Disorder, Major | 2 | 2011 | 4808 | 0.050 |
Why?
|
| Hospital Charges | 1 | 2003 | 345 | 0.050 |
Why?
|
| Female | 18 | 2023 | 396112 | 0.050 |
Why?
|
| Methionine | 2 | 1995 | 569 | 0.050 |
Why?
|
| Stereotaxic Techniques | 1 | 2003 | 551 | 0.050 |
Why?
|
| Motivation | 1 | 2011 | 2018 | 0.050 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 698 | 0.040 |
Why?
|
| Dopamine | 2 | 2005 | 1582 | 0.040 |
Why?
|
| Avoidance Learning | 1 | 2021 | 248 | 0.040 |
Why?
|
| Task Performance and Analysis | 2 | 2018 | 770 | 0.040 |
Why?
|
| Dystonic Disorders | 1 | 2004 | 353 | 0.040 |
Why?
|
| Action Potentials | 1 | 2007 | 1838 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 2021 | 234 | 0.040 |
Why?
|
| Affective Symptoms | 1 | 2021 | 417 | 0.040 |
Why?
|
| Radiosurgery | 1 | 2008 | 1328 | 0.040 |
Why?
|
| Psychopathology | 1 | 2021 | 435 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2021 | 912 | 0.040 |
Why?
|
| Interview, Psychological | 1 | 2021 | 812 | 0.040 |
Why?
|
| Brain Injuries | 1 | 2010 | 2060 | 0.040 |
Why?
|
| Motor Activity | 2 | 2000 | 2704 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 5767 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2003 | 635 | 0.040 |
Why?
|
| Parvovirinae | 1 | 2017 | 10 | 0.040 |
Why?
|
| Aged | 11 | 2023 | 171117 | 0.030 |
Why?
|
| Tropanes | 1 | 2015 | 47 | 0.030 |
Why?
|
| Adult | 12 | 2021 | 223044 | 0.030 |
Why?
|
| Middle Aged | 13 | 2018 | 223009 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1995 | 696 | 0.030 |
Why?
|
| Male | 16 | 2023 | 363698 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2018 | 65188 | 0.030 |
Why?
|
| Somatoform Disorders | 1 | 2016 | 425 | 0.030 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 39193 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 412 | 0.030 |
Why?
|
| Efferent Pathways | 1 | 1993 | 164 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 752 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 1991 | 113 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 16047 | 0.020 |
Why?
|
| Dependovirus | 1 | 2017 | 721 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 1978 | 0.020 |
Why?
|
| Fingers | 2 | 2007 | 509 | 0.020 |
Why?
|
| Logistic Models | 1 | 2005 | 13266 | 0.020 |
Why?
|
| Cholera Toxin | 1 | 1993 | 563 | 0.020 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15880 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2017 | 12437 | 0.020 |
Why?
|
| Neurosurgical Procedures | 2 | 2013 | 2074 | 0.020 |
Why?
|
| Interneurons | 1 | 1994 | 593 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2011 | 18071 | 0.020 |
Why?
|
| Gold | 1 | 1993 | 482 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 1993 | 11022 | 0.020 |
Why?
|
| Cell Count | 1 | 1993 | 1823 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2476 | 0.020 |
Why?
|
| Mouth | 1 | 1991 | 381 | 0.020 |
Why?
|
| Introns | 1 | 2011 | 966 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2008 | 36532 | 0.020 |
Why?
|
| Foot | 1 | 1991 | 573 | 0.020 |
Why?
|
| Music | 1 | 2010 | 249 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 12976 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 1994 | 1445 | 0.020 |
Why?
|
| Animals | 6 | 1995 | 168764 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 8923 | 0.020 |
Why?
|
| Decision Making | 1 | 2018 | 3965 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3615 | 0.010 |
Why?
|
| Comorbidity | 1 | 2018 | 10563 | 0.010 |
Why?
|
| Outpatients | 1 | 2011 | 1595 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2015 | 3595 | 0.010 |
Why?
|
| United States | 3 | 2017 | 72903 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2015 | 3967 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 6547 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2015 | 12768 | 0.010 |
Why?
|
| Toes | 1 | 2000 | 209 | 0.010 |
Why?
|
| Saccades | 1 | 2000 | 230 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2844 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2007 | 6203 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 11888 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7875 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 14751 | 0.010 |
Why?
|
| Prevalence | 1 | 2013 | 15842 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22223 | 0.010 |
Why?
|
| Oxygen | 1 | 2007 | 4241 | 0.010 |
Why?
|
| Haplorhini | 1 | 1994 | 520 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 81514 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 26318 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12807 | 0.010 |
Why?
|
| Movement Disorders | 1 | 1994 | 461 | 0.010 |
Why?
|
| Learning | 1 | 1994 | 1755 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2008 | 54802 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20124 | 0.000 |
Why?
|
| Time Factors | 1 | 2003 | 40065 | 0.000 |
Why?
|
| Young Adult | 1 | 2008 | 59889 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2003 | 41649 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2003 | 59489 | 0.000 |
Why?
|